Forbes November 17, 2023
Although it seems an unlikely place to study a psychedelic drug, the state of Kentucky could be the first to fund research into ibogaine. At the end of the month, a summit in La Grange will offer Kentuckians a chance to learn about it and other potential “breakthrough” treatments for opioid use disorder.
State Commission Considers Funding Psychedelic Research
In 2022, Kentucky Attorney General Daniel Cameron reached settlements of more than $842 million with opioid producers for their role in exacerbating the opioid epidemic. The Bluegrass state has been hit particularly hard by the crisis, where more than 9,000 people have died of an overdose since 2018.
The state established the Kentucky Opioid Abatement Advisory Commission (KYOAAC) to allocate the...
Today's Sponsors
Today's Sponsor